We provide patient support, education, and research for a cure for Primary Immunodeficiency (PI).
|
|
|
Immunodeficiency Canada's 7th Annual sCID Symposium
|
|
Immunodeficiency Canada's 7th Annual sCID Symposium is taking place on October 24th, 2019, at the Hotel Bonaventure in Montreal, Quebec, from 1:30-5:30 pm.
Abstract competition presenters
at the symposium will be:
- Alanna Chomyn, "A case report of Cernunnos deficiency with an evolving phenotype, autoimmunity, and cutaneous granulomas."
- Keelia Farrel, "Variable spectrum of organ involvement in siblings with LRBA deficiency."
- Lucy Duan, "Long-term PEG-ADA enzyme replacement therapy in a patient with partial adenosine deaminase deficiency."
- Noreen Choe, "Positive newborn screen: A case of a novel mutation for Artemis deficiency."
- Ori Scott, "Survival of Patients with Severe Combined Immunodeficiency in the Newborn Screening Era: A Single-Centre Experience 2013-2019."
- Shamud Sud, "Intermittent hypereosinophilia in a pediatric patient with X-linked hyper-IgM."
- Elliot James, "A case of chronic granulomatous disease due to a rare de novo mutation in the CYBB."
- Amarilla B. Mandola, "Novel genetic cause of autoimmune lymphoproliferative syndrome."
- Stephanie Erdle, "Novel BTK variant in a patient with bronchiectasis and B cell lymphopenia."
Keynote Speakers
at Symposium:
- Amit Nahum, "Novel BTK variant in a patient with bronchiectasis and B cell lymphopenia."
- Oana Caluseriu, "A new form of SCID is underlined by NF-κB signaling abnormalities."
- Jolan Waler, "Cytopenias of Many Kinds: An emerging face of Primary Immunodeficiencies."
Click the button below to register for the Immunodeficiency Canada 7th sCID symposium. (Choose #15 when registering).
|
|
Newborn Screening in Manitoba
|
|
The Manitoba Newborn Screening Program will expand in 2020. The screening program for all newborn children will soon include severe combined immune deficiency (SCID), a group of rare genetic diseases affecting a child’s immune system. As such, in Manitoba, every newborn can be checked for uncommon or rare diseases through the Manitoba Newborn Screening Program. The universal hearing screening program was implemented in 2016, allowing early detection of congenital hearing loss in children with the opportunity to develop strong cognitive, speech-processing, and learning skills.
|
|
Newborn Screening in Alberta
|
|
As of May 6th, 2019, Alberta Health has added the screening of SCID to their Newborn Metabolic Screening (NMS) Panel. Alberta is the 4th province/territory in Canada to screen for SCID. Congratulations to the province of Alberta!
|
|
|
|
LymphoSign Journal (the official journal of Immunodeficiency Canada) is available for immunologists by subscription and open-access (after six months from date of publication). For more information contact:
editorialoffice@lymphosign.com
.
The latest published issue of LymphoSign Journal. 01 September 2019 features:
New considerations in hematopoietic stem cell transplantation for severe combined immunodeficiency: how did newborn screening change our field, and can we finally break the glass ceiling for haploidentical transplantation?
Nufar Marcus
Novel heterozygous NFKB1 mutation—variable penetrance in a family cohort
Amarilla B. Mandola, Nigel Sharfe
Histopathological features of patients with chronic granulomatous disease
Paria Kashani, Haiying Chen
Strategies for managing paediatric patients in immunoglobulin clinical trials
Brenda Reid
|
|
The next PI Webcast takes place on December 2nd, 2019.
- Presenting Site: Winnipeg Health Sciences Centre
- Presenters: Chun Che, Karver Zaborniak
|
|
IPIC 2019:
4th edition of the International Primary Immunodeficiencies Congress to take place in Madrid, Spain from November 6-8th, 2019
ACAAI Annual Meeting 2019:
November 7-11th, 2019 at the George R. Brown Convention Center, Houston, Texas.
|
|
|
|
Joseph Zuraw, Senior Director of Public Affairs and Lauren Syring, Manager of Public Affairs of Grifols, Washington, visited Richard Thompson, CEO, at Immunodeficiency Canada on University Avenue, Toronto.
“We really enjoyed spending time with you in your new office and hearing about all the great achievements and initiatives of Immunodeficiency Canada. We look forward to continuing our long-standing partnership.”
Lauren Syring
|
|
Immunodeficiency Canada Moved
|
|
Immunodeficiency Canada moved to 439 University Avenue, Suite 848, Toronto, Ontario, M5G 1Y8.
Richard Thompson, CEO, extends a special thank you to Andrew and Matthew of Cushman & Wakefield in helping Immunodeficiency Canada find a new home in a very tight rental market in Toronto. Andrew and Matthew work with companies in the technology, insurance, healthcare, and not-for-profit sectors. They help these companies find the best possible workspace to allow them to meet their business objectives, account for growth, and to help them attract and retain top talent. You can reach Andrew at 416-359-2449 and
andrew.boutilier@cushwake.com
or Matthew at 416-359-2446 and
matthew.mctavish@cushwake.com
.
|
|
Andrew Boutilier
Senior Associate
|
|
Matthew McTavish
Vice President, Broker
|
|
Newsletter Editor:
Dana Ewachow
Contributors:
Richard Thompson, Shirley Lau, Cindy Chen, Linda Vong
|
|
Immunodeficiency Canada is supported by our Cornerstone Sponsors:
|
|
Immunodeficiency Canada is supported by our Builder Sponsors:
|
|
Connect with us on social media:
|
|
|
|
|
|
|
|
|
|
